Generic Cytomel ( Liothyronine )

Buy Generic Cytomel (Liothyronine) without prescription in Canada

Cytomel (Liothyronine 20 mcg): Comprehensive Patient Information for Canada

Basic Product Information

Mechanism of Action

In simple terms: Cytomel is a synthetic form of triiodothyronine (T3), the active thyroid hormone your body naturally produces. It works by entering your cells and telling your DNA to produce proteins that control your metabolism, energy use, growth, and development. Because it is the active form of thyroid hormone, it works faster than other thyroid medications like levothyroxine (T4), which your body must first convert to T3.

For specialists: Thyroid hormones exert their physiologic actions through control of DNA transcription and protein synthesis. Triiodothyronine (T3) and L-thyroxine (T4) diffuse into the cell nucleus and bind to thyroid receptor proteins attached to DNA. This hormone nuclear receptor complex activates gene transcription and synthesis of messenger RNA and cytoplasmic proteins. The physiological actions of thyroid hormones are produced predominantly by T3, the majority of which (approximately 80%) is derived from T4 by deiodination in peripheral tissues. T3 binds less firmly than T4 in the serum, enters peripheral tissues more readily, and binds to specific nuclear receptors to initiate hormonal and metabolic effects. In vitro studies indicate that T3 increases aerobic mitochondrial function, thereby increasing the rates of synthesis and utilization of myocardial high-energy phosphates. The onset of activity of liothyronine sodium occurs within a few hours, and maximum pharmacologic response occurs within 2 or 3 days.

Pharmacokinetics

• Absorption: T3 is almost totally absorbed, with 95 percent absorbed within 4 hours of oral administration.
• Distribution: Liothyronine sodium (T3) is not firmly bound to serum protein, unlike levothyroxine (T4), which has a higher affinity for thyroid-binding globulin and thyroid-binding prealbumin. This difference partially explains the higher serum levels and longer half-life of T4 compared with T3. Only about 0.5% of circulating T3 is free and metabolically active.
• Metabolism: The major pathway of thyroid hormone metabolism is through sequential deiodination. Approximately 80% of circulating T3 is derived from peripheral T4 by monodeiodination. The liver is the major site of degradation for both T4 and T3. T3 is further deiodinated to diiodothyronine. Thyroid hormones are also metabolized via conjugation with glucuronides and sulfates and excreted directly into the bile and gut where they undergo enterohepatic recirculation.
• Elimination: Thyroid hormones are primarily eliminated by the kidneys. A portion of the conjugated hormone reaches the colon unchanged and is eliminated in the feces. The biological half-life is about 2 to 1/2 days. The elimination half-life of liothyronine is approximately 25 hours in adults.
• Onset of Action: The onset of activity occurs within a few hours. Maximum pharmacologic response occurs within 2 or 3 days.
• Duration of Action: The biological half-life is approximately 2.5 days, requiring once-daily dosing to maintain steady-state levels.

Uses in Daily Life and Best Practice Advice

Liothyronine is prescribed in Canada for the treatment of hypothyroidism and related thyroid disorders. Your physician will determine the appropriate use and dose based on your specific medical situation.

• Typical Uses: Replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is also used as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer, and as a diagnostic agent in thyroid suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.
• Administration: Administer orally once daily. The dose should be individualized according to patient response and laboratory findings.
• Monitoring: Adequacy of therapy is determined with periodic monitoring of TSH and T3 levels as well as clinical status. In patients with secondary or tertiary hypothyroidism, serum TSH is not a reliable measure of dose adequacy, and serum T3 levels should be used to monitor therapy.
• Do Not Stop Without Medical Advice: Generally, replacement therapy is to be taken for life. Do not stop taking this medication without consulting your physician.

Morning vs. Evening Dosing

Liothyronine is typically taken once daily. There is no specific clinical recommendation for morning versus evening dosing. Taking it at the same time each day helps maintain consistent hormone levels. Always follow the schedule recommended by your physician.

• Once Daily: The standard dose is taken once daily.
• Consistency: Take liothyronine at the same time each day to ensure consistent effects.
• Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.
• Professional Guidance: Your healthcare provider may adjust the timing based on your response to treatment.

Administration With or Without Food

Liothyronine can be taken with or without food. However, some medications and supplements can interfere with its absorption. Take liothyronine at least 4 hours apart from bile acid sequestrants (e.g., cholestyramine, colesevelam, colestipol) and ion exchange resins (e.g., kayexalate, sevelamer).

• Take the tablet with a full glass of water.
• Liothyronine can be taken with or without food.
• Separate administration from bile acid sequestrants and ion exchange resins by at least 4 hours.
• Avoid taking liothyronine at the same time as antacids, iron supplements, or calcium supplements, as these may reduce its absorption.

Interaction Warnings

Indications for Liothyronine

"Off-label" means use outside the official approved indication, usually based on current medical guidelines and scientific evidence.

Dosing According to Clinical Indication

Doses should always be adjusted according to the advice of your physician and depending on your health condition. Liothyronine has a rapid onset of action, and residual effects of other thyroid preparations may persist for the first several weeks after initiating therapy. When switching a patient from levothyroxine or desiccated thyroid to liothyronine, discontinue the other medication, initiate a low dose of liothyronine, and increase gradually according to response.

Side Effects and Safety Profile

Guidelines for Correct Use

• Take liothyronine exactly as prescribed by your physician. Do not change your dose without medical advice.
• Take the tablet with a full glass of water, with or without food, at the same time each day.
• Separate administration from bile acid sequestrants and ion exchange resins by at least 4 hours.
• Do not stop taking this medication without consulting your physician. Replacement therapy is generally lifelong.
• Do not use this medication for weight loss. It is not effective for weight reduction in euthyroid patients and may cause serious harm.
• Keep all medical appointments for monitoring of thyroid function tests (TSH, T3) and clinical response.
• Inform every healthcare provider (including dentists, surgeons, and pharmacists) that you are taking liothyronine.
• If you are pregnant, planning to become pregnant, or breastfeeding, consult your physician before use. Dose requirements may change during pregnancy.
• If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double the dose.
• Store at room temperature (20–25°C) in a dry place. Keep out of reach of children.

Alternative Treatment Options

• Levothyroxine (T4) (e.g., Synthroid, Eltroxin, generic): The standard first-line treatment for hypothyroidism. It is a synthetic form of thyroxine (T4), which the body converts to T3 as needed. It has a longer half-life (about 6 days) and provides more stable blood levels. The Royal College of Physicians recommends levothyroxine alone for the treatment of hypothyroidism due to overwhelming evidence supporting its use.
• Desiccated Thyroid Extract (e.g., Armour Thyroid, Nature-Throid): A natural preparation derived from porcine thyroid glands that contains both T4 and T3. It is not recommended by the Royal College of Physicians due to inconsistent potency and lack of proven benefit.
• Liotrix (Thyrolar): A synthetic combination of T4 and T3 in a fixed ratio. Available in some jurisdictions but not commonly used in Canada.
• Compounded Liothyronine: For patients who require a 20 mcg dose, which is not commercially available in Canada, a compounding pharmacy can prepare customized liothyronine capsules or tablets at the prescribed strength.

Comparison: Liothyronine (T3) is distinguished from levothyroxine (T4) by its faster onset of action, shorter half-life, and direct biological activity. It is the active form of thyroid hormone and does not require conversion by the body. However, its shorter half-life requires once-daily dosing, and its rapid onset can make it more difficult to manage, particularly in elderly patients or those with cardiovascular disease. Levothyroxine remains the preferred first-line therapy for most patients with hypothyroidism due to its long half-life, stable blood levels, and extensive evidence base. Liothyronine is generally reserved for specific situations, such as when impairment of peripheral conversion of T4 to T3 is suspected, when absorption of levothyroxine is questionable, or as an adjunct in the management of well-differentiated thyroid cancer. Your physician will determine the best option for your specific condition.

Legal Status, Registration, and Coverage in Canada

• Registration: Liothyronine sodium is authorized for sale in Canada by Health Canada as a prescription drug. Cytomel (Pfizer Canada Inc.) is available in 5 mcg and 25 mcg tablets. Generic formulations include TEVA-Liothyronine (5 mcg and 25 mcg), AURO-Liothyronine (5 mcg), and ZDS-Liothyronine (25 mcg).
• Prescription Status: Prescription only in Canada. Liothyronine is classified as a Schedule I drug under NAPRA's national drug scheduling framework.
• Coverage: Coverage varies by province and territory. In Ontario, ZDS-Liothyronine 25 mcg is listed as an Off-Formulary Interchangeable product and Exceptional Access Program product at a drug benefit price of $1.2595 per tablet. In Quebec, Cytomel and generic liothyronine are covered under the RAMQ formulary. In Newfoundland and Labrador, TEVA-Liothyronine 5 mcg is listed as a benefit, and Cytomel 5 mcg is listed as interchangeable. Generic formulations may be more affordable than brand-name products.
• Pharmacovigilance: Adverse reactions should be reported to Health Canada's MedEffect Canada program at 1-866-234-2345.

Recent Research and Clinical Guidelines (2022–2026)

• The National Institute for Health and Care Excellence (NICE) guidelines state that liothyronine (alone or in combination with levothyroxine) is not recommended for treating people with primary hypothyroidism. The guidelines advise: "Do not routinely offer liothyronine for primary hypothyroidism".
• The Royal College of Physicians recommends that levothyroxine alone is used in the treatment of hypothyroidism due to overwhelming evidence supporting its use. Liothyronine may be recommended as a sole agent by an endocrinologist when absorption of levothyroxine is questionable or impairment of peripheral conversion of T4 to T3 is suspected.
• Liothyronine (T3) has a much shorter half-life (1 day vs. 6 days for T4), and steady-state levels cannot be maintained with once-daily dosing. The Royal College of Physicians does not recommend prescribing levothyroxine with additional liothyronine due to lack of proven benefit and potential harm.
• Current clinical practice in Canada continues to emphasize levothyroxine as the preferred first-line therapy for hypothyroidism. Liothyronine is generally reserved for specific clinical situations and should be initiated only under the guidance of an endocrinologist.
• Research continues to explore the role of liothyronine in combination with levothyroxine for patients with persistent symptoms of hypothyroidism despite adequate levothyroxine replacement, though evidence for benefit remains limited and inconsistent.
• A 2025 review on personalized approaches to hypothyroidism discusses the growing interest in adding or switching to liothyronine (LT3), especially for patients who may not convert T4 to T3 efficiently.

Availability and Supply in Canada

Prices and availability may vary by province, territory, and pharmacy. A 20 mcg tablet is not commercially available in Canada; if a 20 mcg dose is prescribed, it may require compounding by a specialty pharmacy or may be achieved by combining available strengths under medical supervision. Generic formulations are generally more affordable than brand-name products. Check with your local pharmacy for current pricing and availability.

Frequently Asked Questions (FAQ)

1. What is Cytomel used for?
   Cytomel (liothyronine) is a synthetic form of the thyroid hormone triiodothyronine (T3). It is used to treat hypothyroidism (underactive thyroid), to suppress thyroid-stimulating hormone (TSH) in the management of well-differentiated thyroid cancer, and as a diagnostic agent in thyroid suppression tests.
2. How does Cytomel work?
   Cytomel works by entering your cells and binding to thyroid receptors on your DNA. This activates gene transcription and the production of proteins that control your metabolism, energy use, growth, and development. It is the active form of thyroid hormone, so it works faster than levothyroxine (T4), which your body must first convert to T3.
3. What is the correct dose of Cytomel?
   The usual starting dose for adults is 25 mcg once daily, which may be increased by up to 25 mcg/day every 1 to 2 weeks. The usual maintenance dose is 25 to 75 mcg once daily. For elderly patients or those with cardiovascular disease, the starting dose is 5 mcg once daily, increased by 5 mcg increments. Your physician will determine the appropriate dose for your condition.
4. Can I take Cytomel with food?
   Yes. Cytomel can be taken with or without food. However, take it at least 4 hours apart from bile acid sequestrants (e.g., cholestyramine) and ion exchange resins (e.g., kayexalate), as these can reduce its absorption.
5. What should I do if I miss a dose?
   If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.
6. Can I use Cytomel for weight loss?
   No. Thyroid hormones, including Cytomel, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity.
7. What are the serious side effects of Cytomel?
   Serious side effects are primarily those of hyperthyroidism due to therapeutic overdosage and include cardiac arrhythmias, myocardial infarction, dyspnea, and severe allergic reactions. Seek immediate medical attention if you experience chest pain, rapid or irregular heartbeat, shortness of breath, or signs of a severe allergic reaction.
8. Is Cytomel safe during pregnancy?
   Cytomel should be used during pregnancy only if clearly needed. Thyroid hormone dose requirements may increase during pregnancy. Monitor serum TSH and free T4 as soon as pregnancy is confirmed and during each trimester. Consult your physician if you are pregnant or planning to become pregnant.
9. Is Cytomel safe during breastfeeding?
   It is not known whether liothyronine is excreted in human breast milk. Consult your physician before use if breastfeeding.
10. Are there alternatives to Cytomel?
    Yes. The standard first-line treatment for hypothyroidism is levothyroxine (T4), which has a longer half-life and provides more stable blood levels. Other alternatives include desiccated thyroid extract and liotrix (a synthetic combination of T4 and T3). Your physician will determine the best option for your specific condition.
11. Is Cytomel covered by Canadian health insurance?
    Coverage varies by province and territory. In Ontario, ZDS-Liothyronine 25 mcg is listed as an Off-Formulary Interchangeable product and Exceptional Access Program product. In Quebec, Cytomel and generic liothyronine are covered under the RAMQ formulary. In Newfoundland and Labrador, TEVA-Liothyronine 5 mcg is listed as a benefit. Check with your provincial drug plan and private insurance provider for coverage details.